The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Lutein (L) and zeaxanthin (Z) are dietary carotenoids derived from dark green leafy vegetables, orange and yellow fruits that form the macular pigment of the human eyes. It was hypothesized that they protect against visual disorders and cognition diseases, such as age-related macular degeneration (AMD), age-related cataract (ARC), cognition diseases, ischemic/hypoxia induced retinopathy, light damage of the retina, retinitis pigmentosa, retinal detachment, uveitis and diabetic retinopathy. The mechanism by which they are involved in the prevention of eye diseases may be due their physical blue light filtration properties and local antioxidant activity. In addition to their protective roles against light-induced oxidative damage, there are increasing evidences that L and Z may also improve normal ocular function by enhancing contrast sensitivity and by reducing glare disability. Surveys about L and Z supplementation have indicated that moderate intakes of L and Z are associated with decreased AMD risk and less visual impairment. Furthermore, this review discusses the appropriate consumption quantities, the consumption safety of L, side effects and future research directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
A Structural MRI Study of Human Brain Development from Birth to 2 Years
Knickmeyer, R. C., Gouttard, S., Kang, C., Evans, D., Wilber, K., Smith, J. K., Hamer, R. M., Lin, W., Gerig, G., & Gilmore, J. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3479-08.2008 · Cited by 1,151
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
B IOLOGIC M ECHANISMS OF THE P ROTECTIVE R OLE OF L UTEIN AND Z EAXANTHIN IN THE E YE
Krinsky, N. I., Landrum, J. T., & Bone, R. A. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073307 · Cited by 779
(2004) · doi:10.1007/978-3-0348-7836-4 · Cited by 652
Chew, E. Y., Clemons, T. E., SanGiovanni, J. P., Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7376 · Cited by 415 · cited 8×
“Among older persons with AMD, oral supplementation with LCPUFAs or L/Z had no statistically significant effect on cognitive function [107].”
BackgroundInfluentialLutein: More than just a filter for blue light
Kijlstra, A., Tian, Y., Kelly, E. R., & Berendschot, T. T. J. M. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.03.002 · Cited by 349 · cited 2×
“MPs also have anti-inflammatory and light-screening properties [7,9].”
BackgroundEnrich the environment to empower the brain
Sale, A., Berardi, N., & Maffei, L. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.004 · Cited by 341
Cited by
Pistollato, F., Iglesias, R. C., Ruiz, R., Aparicio, S., Crespo, J., Lopez, L. D., Manna, P. P., Giampieri, F., & Battino, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.012 · Cited by 247
Ampofo, J., & Abbey, L. (2022) · Foods · doi:10.3390/foods11121744 · Cited by 237
Applying Seaweed Compounds in Cosmetics, Cosmeceuticals and Nutricosmetics
López-Hortas, L., Flórez-Fernández, N., Torres, M. D., Ferreira-Anta, T., Casas, M. P., Balboa, E. M., Falqué, E., & Domínguez, H. (2021) · Marine Drugs · doi:10.3390/md19100552 · Cited by 168
Souyoul, S. A., Saussy, K. P., & Lupo, M. P. (2018) · Dermatology and Therapy · doi:10.1007/s13555-018-0221-x · Cited by 159
The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence
Varesi, A., Chirumbolo, S., Campagnoli, L. I. M., Pierella, E., Piccini, G. B., Carrara, A., Ricevuti, G., Scassellati, C., Bonvicini, C., & Pascale, A. (2022) · Antioxidants · doi:10.3390/antiox11071224 · Cited by 145
Cano, A., Turowski, P., Ettcheto, M., Duskey, J. T., Tosi, G., Sánchez-López, E., García, M. L., Camins, A., Souto, E. B., Ruiz, A., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00864-x · Cited by 122
“Although this molecule has shown promising beneficial effects, such as anti-inflammatory, antioxidant, and anti-cancer activity, its reduced solubility and bioavailability have restricted its use in the food and pharmaceutical industries [175].”
BackgroundBioactive compounds from micro-algae and its application in foods: A review
Siddhnath, Surasani, V. K. R., Singh, A., Singh, S. M., Hauzoukim, Murthy, L. N., & Baraiya, K. G. (2024) · Discover Food · doi:10.1007/s44187-024-00096-6 · Cited by 42
Metadata
- Authors
- Jia, Y.-P., Sun, L., Yu, H.-S., Liang, L.-P., Li, W., Ding, H., Song, X.-B., & Zhang, L.-J.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-04-20
- Volume
- 22
- Issue
- 4
- Pages
- 610
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2605454194
- Cited by
- 137
- References
- 14
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.